Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma. - Wikidata - awgldk - TriplyDB

Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma.

Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma.

http://www.wikidata.org/entity/Q36616704

about

Immunotherapy of Childhood Sarcomas Immunotherapeutic Intervention against Sarcomas.Combining cancer vaccines with chemotherapy.Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins Strategies and developments of immunotherapies in osteosarcoma Adult human sarcomas. I. Basic science.Role of monoclonal antibodies in tumor-specific immunity.Current concepts on the surgical and medical management of osteosarcoma.Antibodies designed as effective cancer vaccines.Nanoparticles: a promising modality in the treatment of sarcomas.A multi-targeted approach to treating bone metastases.Sarcoma immunotherapy: past approaches and future directions.Brain Tumor Immunotherapy: What have We Learned so Far?Immunotherapy in Sarcoma: Future Horizons.Progress and opportunities for immune therapeutics in osteosarcoma.Immune-based therapies for sarcoma.Identification of Key Gene Modules in Human Osteosarcoma by Co-Expression Analysis Weighted Gene Co-Expression Network Analysis (WGCNA).

P2860

Q26795369-7ACF7EEA-423F-4C7B-914B-47EA7D48D9EC Q34196481-4D2A10CC-7A21-4281-A0E2-A2FC28B7E920 Q36327092-D9B5E516-A464-4271-8FF0-BD50EE6BB3FA Q36386109-5D4858F1-4CA0-42A2-8C6E-4CD0C755588F Q36503128-9D7F4395-7428-49C7-8D8C-CAC3D00E53AD Q36691805-8831CB08-EBA6-456B-9399-082EA0BC8F54 Q36739762-27D6F507-9A9E-4D7E-87B7-CE46141EED41 Q37242673-885403FF-E9FD-4E33-AF2F-71456601BCFB Q37273469-0B2BC2AA-7D0E-4D34-A136-DC51CD2627A9 Q37761069-3360B983-BFF5-40CC-8AE3-2898D2AF0F32 Q38175846-F90D473C-8821-494D-8858-3AFE0997A57E Q38207986-B554BCD3-3B29-4B54-93A5-EB1DCEE0D959 Q38542113-B80E1AD1-FF4E-497D-9ADF-CDC1B202087A Q38596093-4AE76DF4-C99D-400D-ABFF-5860D6C1639E Q38948905-50F6F4E8-9255-4711-86FB-1C82CBC8C6DC Q41931033-C07330AE-79B3-413D-ABE5-0875C894EEC2 Q48290693-758A746C-9A3A-4663-85B8-1BD1D6809549

P2860

Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma.

http://www.wikidata.org/entity/Q36616704

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Immune responses to the 105AD7 ...... hemotherapy, for osteosarcoma.

@ast

Immune responses to the 105AD7 ...... hemotherapy, for osteosarcoma.

@en

type

label

Immune responses to the 105AD7 ...... hemotherapy, for osteosarcoma.

@ast

Immune responses to the 105AD7 ...... hemotherapy, for osteosarcoma.

@en

prefLabel

Immune responses to the 105AD7 ...... hemotherapy, for osteosarcoma.

@ast

Immune responses to the 105AD7 ...... hemotherapy, for osteosarcoma.

@en

P1433

Q36616704-E92E308C-CF23-4C40-913E-B820604B0A4C

P1476

Q36616704-9F04D997-04E1-49E3-8D4E-F1F2D44EE5D7

P2093

Q36616704-16683FEE-CE26-4B74-A34F-D2F6D36066C6

Q36616704-2775B144-5B23-4AFF-AF54-E3958FF4B32A

Q36616704-3A2080A3-0F10-4C1C-9045-99855A6568C5

Q36616704-655AB766-B64F-4741-B0CB-04D6BF9E7CCB

Q36616704-7D4701FF-B6E1-4D58-B2BA-4F14A5A9EA9E

Q36616704-8CE06928-0D02-44F7-BCC8-B55A3268A190

Q36616704-95DD595B-EA53-4C28-9549-6D13089B9F69

Q36616704-BC4701B9-6AEE-4683-A8FB-BD654A1F6705

Q36616704-C54CFE40-EE2F-4754-A936-383BF1DC8347

Q36616704-D4238C6A-6126-4637-8143-1E0C4D90552C

P2860

Q36616704-09FED99B-B6C2-420D-AF42-742223CEE2C5

Q36616704-104D491D-CC1B-4FD0-9B0F-8F66BBEB6AFD

Q36616704-1C1FEA8D-7B59-40C5-A890-778104441867

Q36616704-4B592AFF-82C7-488B-87A5-F5A551209DB0

Q36616704-562F4539-7E0F-414C-9DC2-A73EEF5B1CD9

Q36616704-99593E5B-1299-4D53-8E21-9D46EC81952B

Q36616704-B6A28FE9-3400-471C-B446-AE1BEC9A8C8F

Q36616704-FCDFB04F-7D86-4BF8-BDAC-96F2B0980BD1

P2888

Q36616704-0B7EC05C-0BD1-4504-A515-49EB2A50D14B

P304

Q36616704-E082C508-65E6-498E-BBB3-3CE277D1E31E

P31

Q36616704-8ACE684D-9710-4C8C-B322-33C14FF07309

P356

Q36616704-9B004497-3399-473A-B46D-E51652BF7658

P407

Q36616704-119C6592-FDF3-4496-AEB4-66E1DE29536A

P433

Q36616704-1370A888-3487-43FA-BCA3-F68B856123EE

P478

Q36616704-D3B3B068-F769-47B6-9680-547FA6612B3A

P50

Q36616704-F60AF9F6-1CDA-4DED-9B7F-A28DF260DF34

P577

Q36616704-630021FB-E684-40F2-9072-A9DAFF6A4224

P5875

Q36616704-FEDCBEB8-ECFE-498A-A19F-9F3DB0987D38

P698

Q36616704-0A26BA46-1EC2-4DEF-9685-D37A00706715

P921

Q36616704-132E8088-620F-4103-A088-2F9F159A6683

P932

Q36616704-450AC9A9-F371-47F8-8C9D-8F172C13CA09

P356

P1433

British Journal of Cancer

P1476

Immune responses to the 105AD7 ...... chemotherapy, for osteosarcoma

@en

P2093

B Campbell

http://www.w3.org/2001/XMLSchema#string

C Douglas

http://www.w3.org/2001/XMLSchema#string

C Pagonis

http://www.w3.org/2001/XMLSchema#string

C Wilton

http://www.w3.org/2001/XMLSchema#string

G Halbert

http://www.w3.org/2001/XMLSchema#string

I Lewis

http://www.w3.org/2001/XMLSchema#string

J Hale

http://www.w3.org/2001/XMLSchema#string

J Whelan

http://www.w3.org/2001/XMLSchema#string

K Pritchard-Jones

http://www.w3.org/2001/XMLSchema#string

L G Durrant

http://www.w3.org/2001/XMLSchema#string

P2860

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup.

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer

Induction of delayed hypersensitivity to human tumor cells with a human monoclonal anti-idiotypic antibody.

Sample size tables for exact single-stage phase II designs.

105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses.

Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs

P2888

P304

1358-1365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602500

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7936805

http://www.w3.org/2001/XMLSchema#string

P698

15798769

http://www.w3.org/2001/XMLSchema#string

P921

P932

2361999

http://www.w3.org/2001/XMLSchema#string